---
title: Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy
date: '2024-06-12'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38865660/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&fc=20220923065203&ff=20240613182110&v=2.18.0.post9+e462414
source: (((leukemia) OR (lymphoma)) OR (myeloma)) AND (Stanford University[Affiliation])
description: 'CONCLUSIONS: Our results highlight the rarity of second tumors and provide
  a framework for defining clonal relationships and viral vector monitoring. (Funded
  by the National Cancer Institute and ...'
disable_comments: true
---
CONCLUSIONS: Our results highlight the rarity of second tumors and provide a framework for defining clonal relationships and viral vector monitoring. (Funded by the National Cancer Institute and ...